Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 20 most recent Form 4 transactions.
| $34K |
| -100.0% |
| Open the original filing on SEC.gov |
| Nov 11 | PVLA | Palvella Therapeutics,… | SSELL◷ | 600 | $168.73 | $101.2K | -75.0% | Open the original filing on SEC.gov |
| Nov 11 | PVLA | Palvella Therapeutics,… | SSELL◷ | 1,200 | $167.75 | $201.3K | -60.0% | Open the original filing on SEC.gov |
| Nov 11 | PVLA | Palvella Therapeutics,… | SSELL◷ | 1,133 | $166.76 | $188.9K | -36.2% | Open the original filing on SEC.gov |
| Nov 11 | PVLA | Palvella Therapeutics,… | SSELL◷ | 1,467 | $165.78 | $243.2K | -31.9% | Open the original filing on SEC.gov |
| Nov 11 | PVLA | Palvella Therapeutics,… | SSELL◷ | 1,650 | $164.14 | $270.8K | -26.4% | Open the original filing on SEC.gov |
| Nov 11 | PVLA | Palvella Therapeutics,… | MEXER◷ | 6,250 | $9.79 | $61.2K | — | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | MEXER◷◆ | 1,984 | — | — | — | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | MEXER◷◆ | 4,266 | — | — | — | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | SSELL◷ | 800 | $172.12 | $137.7K | -100.0% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | SSELL◷ | 550 | $169.03 | $93K | -40.7% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | SSELL◷ | 200 | $167.81 | $33.6K | -12.9% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | SSELL◷ | 1,500 | $166.91 | $250.4K | -49.2% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | SSELL◷ | 1,651 | $165.85 | $273.8K | -35.1% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | SSELL◷ | 1,449 | $164.85 | $238.9K | -23.6% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | SSELL◷ | 100 | $163.34 | $16.3K | -1.6% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | MEXER◷ | 1,984 | $9.79 | $19.4K | +46.5% | Open the original filing on SEC.gov |
| Nov 10 | PVLA | Palvella Therapeutics,… | MEXER◷ | 4,266 | $7.53 | $32.1K | — | Open the original filing on SEC.gov |
| Feb 5 | PVLA | Palvella Therapeutics,… | AGRANT◆ | 64,318 | — | — | — | Open the original filing on SEC.gov |